Generic Name
Sulindac
FDA approval date: April 03, 1990
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet
What is Sulindac?
Carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Sulindac tablets are indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis* 3. Ankylosing spondylitis 4. Acute painful shoulder 5. Acute gouty arthritis.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells (SC01009) Injection for the Treatment of Severe Pneumonia Caused by Viruses
Summary: This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of Menstrual blood-derived Mesenchymal Stem Cells (SC01009) injection for the treatment of severe pneumonia caused by viruses. The purpose of the study is to assess the safety and efficacy of SC01009 injection in combination with standard treatment in patients with severe pn...